E
Cytek Biosciences, Inc. CTKB
$4.11 -$0.065-1.56% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -0.85% -1.86% 3.85% 9.88% 12.59%
Total Other Revenue -- -- -- -- --
Total Revenue -0.85% -1.86% 3.85% 9.88% 12.59%
Cost of Revenue 0.36% -0.65% 6.89% 17.25% 26.91%
Gross Profit -1.83% -2.83% 1.54% 4.49% 3.07%
SG&A Expenses 5.75% 2.60% 1.83% 3.60% 9.30%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 0.88% -1.23% 1.23% 6.70% 14.37%
Operating Income -14.11% -3.58% 16.96% 14.40% -30.10%
Income Before Tax 53.48% 49.10% 63.72% 24.16% -68.06%
Income Tax Expenses -189.03% 179.00% 108.99% 1.18% 134.11%
Earnings from Continuing Operations 63.54% 2.24% 50.45% 27.09% -200.05%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 63.54% 2.24% 50.45% 28.99% -183.89%
EBIT -14.11% -3.58% 16.96% 14.40% -30.10%
EBITDA -16.27% -1.55% 27.01% 25.79% -15.59%
EPS Basic 61.64% -0.82% 49.72% 25.69% -192.94%
Normalized Basic EPS 34.89% 30.33% 45.83% 23.63% -64.74%
EPS Diluted 60.04% -0.33% 43.65% 24.14% -191.19%
Normalized Diluted EPS 34.89% 30.33% 45.83% 25.42% -57.67%
Average Basic Shares Outstanding -3.14% -3.11% -3.45% -2.89% -1.67%
Average Diluted Shares Outstanding -2.81% -2.78% -3.12% -5.39% -5.21%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --